Porcine factor VIII and plasmapheresis in the management of hemophiliac patients with inhibitors
- 1 February 1986
- journal article
- research article
- Published by Wiley in American Journal of Hematology
- Vol. 21 (2), 201-207
- https://doi.org/10.1002/ajh.2830210209
Abstract
Management of hemophiliac patients with inhibitors can be a difficult problem. We report here a patient with severe hemophilia A, a high titer inhibitor, and an abdominal abscess requiring surgery. Despite significant cross reactivity of the inhibitor with porcine FVIII, he was successfully managed with plasmapheresis and porcine FVIII infusions. Other approaches to the management of such patients are briefly reviewed.This publication has 17 references indexed in Scilit:
- Current Status of Therapeutic Plasmapheresis and Related TechniquesPublished by American Medical Association (AMA) ,1985
- Fresh-Frozen PlasmaPublished by American Medical Association (AMA) ,1985
- Hemostatic imbalances produced by plasma exchangeTransfusion, 1984
- Therapeutic Plasma ExchangeNew England Journal of Medicine, 1984
- The Effect of Activated Prothrombin-Complex Concentrate (FEIBA) on Joint and Muscle Bleeding in Patients with Hemophilia A and Antibodies to Factor VIIINew England Journal of Medicine, 1981
- Reactions to low-molecular-weight porcine factor VIII concentrates.BMJ, 1981
- Efficacy of Prothrombin-Complex Concentrates in Hemophiliacs with Antibodies to Factor VIIINew England Journal of Medicine, 1980
- DELIVERY OF HEALTH CARE IN HEMOPHILIAAnnals of the New York Academy of Sciences, 1975
- Thrombogenic Materials in Prothrombin Complex ConcentratesAnnals of Internal Medicine, 1974
- Hemophilia hometransfusion program: Effect on school attendanceThe Journal of Pediatrics, 1972